| human | Q5 |
| P27 | country of citizenship | Norway | Q20 |
| P108 | employer | St. Olavs hospital, Trondheim University Hospital | Q3446347 |
| P734 | family name | Damås | Q122835821 |
| Damås | Q122835821 | ||
| Damås | Q122835821 | ||
| P735 | given name | Jan | Q12173670 |
| Jan | Q12173670 | ||
| Kristian | Q12794332 | ||
| Kristian | Q12794332 | ||
| P106 | occupation | professor | Q121594 |
| researcher | Q1650915 | ||
| P21 | sex or gender | male | Q6581097 |
| Q40627047 | 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases |
| Q44980046 | 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells |
| Q60388177 | A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization |
| Q34426813 | A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells |
| Q39837123 | A complex role of activin A in non-alcoholic fatty liver disease |
| Q47880025 | Abnormal interleukin-7 function in common variable immunodeficiency |
| Q36145827 | Agents targeting inflammation in heart failure |
| Q36425459 | Anti-inflammatory trials in chronic heart failure. |
| Q46513414 | Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways |
| Q57166098 | Anxiety and Depression Symptoms in a General Population and Future Risk of Bloodstream Infection: The HUNT Study |
| Q40150904 | Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study |
| Q58840336 | Body composition and plasma levels of inflammatory biomarkers in COPD |
| Q41160520 | Bronchial microdialysis monitoring of inflammatory response in open abdominal aortic aneurysm repair; an observational study |
| Q36305114 | Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study |
| Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
| Q73690935 | CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells |
| Q73573609 | CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes |
| Q44070141 | CXCL16 in HIV infection - a link between inflammation and viral replication |
| Q37231421 | Chemokines and cardiovascular risk |
| Q44782672 | Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation |
| Q79665134 | Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation |
| Q80265488 | Chemokines in cardiovascular risk prediction |
| Q46778209 | Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES. |
| Q74263491 | Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets |
| Q37700323 | Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release |
| Q99413492 | Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis |
| Q91242823 | Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway |
| Q57225517 | Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation |
| Q54591387 | Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study. |
| Q43540341 | Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis |
| Q38601679 | Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation |
| Q81540101 | Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure |
| Q35091837 | Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality |
| Q24799394 | Cytokines as new treatment targets in chronic heart failure |
| Q45397427 | Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy |
| Q64965929 | Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes? |
| Q37154200 | Early identification of sepsis in hospital inpatients by ward nurses increases 30-day survival |
| Q89400922 | Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial |
| Q54690438 | Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2. |
| Q84586692 | Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes |
| Q40241842 | Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction |
| Q78402091 | Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients |
| Q46131579 | Elevated levels of activin A in clinical and experimental pulmonary hypertension |
| Q44781958 | Elevated levels of activin A in heart failure: potential role in myocardial remodeling |
| Q40327271 | Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization |
| Q79434482 | Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization |
| Q74194624 | Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin |
| Q43575647 | Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS). |
| Q44377514 | Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy |
| Q40368553 | Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis |
| Q35153754 | Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study |
| Q36027498 | Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study |
| Q42335260 | Erratum to: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in mid-Norway: a prospective observational study |
| Q44777046 | Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome |
| Q53158098 | Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure. |
| Q28550697 | Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells |
| Q39152785 | Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. |
| Q46191844 | Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy |
| Q35553707 | Expression of matrix metalloproteinases in patients with Wegener's granulomatosis |
| Q40242687 | Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway |
| Q40536632 | Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease |
| Q41470716 | Genetic variants in the DNA repair gene NEIL3 and the risk of myocardial infarction in a nested case-control study. The HUNT Study |
| Q40094351 | Hepatitis C reinfection after sustained virological response |
| Q46702852 | High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins |
| Q45382212 | Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication |
| Q44437789 | Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease |
| Q39901518 | IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients |
| Q58746571 | IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction |
| Q41536733 | IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy |
| Q44416290 | Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells |
| Q35097101 | Immunomodulating therapy: new treatment modality in congestive heart failure |
| Q83854535 | Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects |
| Q36752011 | Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation |
| Q42207429 | Increased endothelial and macrophage markers are associated with disease severity and mortality in scrub typhus |
| Q80916754 | Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure |
| Q80579654 | Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation |
| Q44820281 | Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors |
| Q35089106 | Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection |
| Q40174095 | Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization |
| Q74292256 | Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure |
| Q54378142 | Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells. |
| Q28200764 | Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation |
| Q40473187 | Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. |
| Q43240307 | Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling |
| Q35756990 | Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin |
| Q36314881 | Inflammation in coronary artery disease: potential role for immunomodulatory therapy |
| Q36198484 | Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications |
| Q78492761 | Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10 |
| Q54786635 | Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. |
| Q83192731 | Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease |
| Q43083652 | Inflammatory role of platelets in acute coronary syndromes |
| Q32055041 | Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes |
| Q50781571 | Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. |
| Q89367585 | Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction |
| Q28195974 | Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets |
| Q39714745 | Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease |
| Q35946350 | Keap1 regulates inflammatory signaling in Mycobacterium avium-infected human macrophages |
| Q40778270 | Low levels of short- and medium-chain acylcarnitines in HIV-infected patients |
| Q51041548 | Microbubbles in the pulmonary artery generated during experimental hepatic radiofrequency ablation is correlated with increased pulmonary arterial pressure. |
| Q74414130 | Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes |
| Q40172387 | Monocyte/macrophage and T cell activation markers are not independently associated with MI risk in healthy individuals - results from the HUNT Study |
| Q39003418 | Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease |
| Q30611192 | Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure |
| Q73942551 | Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure |
| Q40088561 | N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2. |
| Q43056315 | Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. |
| Q83748739 | No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts |
| Q96220491 | Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform |
| Q83070486 | Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients |
| Q45986084 | Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation. |
| Q61066385 | Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity |
| Q47964957 | Platelet activation in heart transplant recipients |
| Q79966465 | Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes |
| Q33785014 | Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality - a prospective study of patients admitted with infection to the emergency department |
| Q44984913 | Potential anti-inflammatory role of activin A in acute coronary syndromes |
| Q36822365 | Potential mechanisms of benefit with thalidomide in chronic heart failure |
| Q36283698 | Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation |
| Q81504025 | Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation |
| Q39742477 | Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation |
| Q43459401 | Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients |
| Q91047010 | Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) |
| Q46721795 | Reconstituted High-Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing Complement Activation |
| Q40401947 | Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever |
| Q36806972 | Role of inflammation in the progression of heart failure |
| Q40361562 | Role of interleukin-10 in atherogenesis and plaque stabilization |
| Q47232016 | SOFA criteria predict infection-related in-hospital mortality in ICU patients better than SIRS criteria and the qSOFA score |
| Q58724610 | Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction |
| Q83244387 | Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients |
| Q89367588 | Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction |
| Q47355225 | Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? |
| Q45269812 | Soluble CD40 ligand in acute and chronic heart failure |
| Q45012612 | Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells |
| Q40878000 | Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway |
| Q28534690 | Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses |
| Q43677519 | Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences |
| Q74397732 | Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects |
| Q36526913 | Systemic inflammation in heart failure--the whys and wherefores |
| Q83161496 | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 |
| Q84738653 | Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease |
| Q81403706 | T cells in coronary artery disease: different effects of different T-cell subsets |
| Q89825287 | TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria |
| Q26751492 | The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review |
| Q59126052 | The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain |
| Q37167783 | The complex role of T-cell-based immunity in atherosclerosis |
| Q34200352 | The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure |
| Q36558817 | The role of intravenous immunoglobulin in the treatment of chronic heart failure |
| Q40361542 | The tumor necrosis factor superfamily in heart failure |
| Q50312267 | The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis |
| Q35768272 | Therapeutic potential of anticytokine therapy in congestive heart failure |
| Q42372557 | Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages |
| Q50325363 | Transcapillary fluid flux and inflammatory response during neonatal therapeutic hypothermia: an open, longitudinal, observational study |
| Q43238382 | Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome |
| Q36266662 | Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study |
| Q63352311 | Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition |
| Q34611580 | Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis |
Search more.